In the US, GLP-1 spending rose from $13 to $72 billion in just five years, making approval tough for patients without diabeteseven as data for arthritis risk and cardiovascular benefits grow
Not all patients experience clinically meaningful improvements in cholesterol, and some may require additional lipid-lowering therapy regardless of weight loss
Introduction: Embarking on the journey of pregnancy involves a multitude of considerations, and for women exploring the potential benefits of GLP-1 medications for weight loss, understanding the implications during pregnancy becomes crucial
The multiple-target drug had better effects, while the single-target drugs showed a significant improvement in steatosis and glucose metabolism, particularly with GLP-1RAs
Supplementary information Rights and permissions Springer Nature or its licensor (e.g
Results vary significantly based on individual absorption and technique quality